Submit manuscript...
Journal of
eISSN: 2373-4426

Pediatrics & Neonatal Care

Case Report Volume 9 Issue 1

Human granulocytic Anaplasmosis: a case report in Mexico

Mar a Elena Haro Acosta,5 Carmen Gorety Soria Rodr guez,1 Natalia Galarza,2 Simi Dhillon,2 Yolanda Correa Bautista,3 Ricardo de Le n Figueroa,4 Joan Dautt Silva,6 Luis Tinoco Gracia7

1Pediatrician and Coordinator in Health Research at IMSS Hospital Gineco Pediatria y Medicina Familiar M xico
2Family Medicine Yuma Regional Medical Center United States
3Pediatric Allergist IMSS Hospital Gineco Pediatr a y Medicina Familiar M xico
4Pediatric Hematologist IMSS Hospital Gineco Pediatr a y Medicina Familiar Mexico
5Sc D Pediatrician and Coordinator in Health Research at IMSS Delegaci n Baja California M xico
6Medical Intern IMSS Hospital Gineco Pediatr a y Medicina Familiar M xico
7Sc D Veterinarian Veterinary Science Research Institute Universidad Aut noma de Baja California M xico

Correspondence: Mar a Elena Haro Acosta Sc D Pediatrician and Coordinator in Health Research at IMSS Delegaci n Baja California Mexicali BC Me xico

Received: January 15, 2019 | Published: February 13, 2019

Citation: Soria-Rodríguez CG, Galarza N, Dhillon S, et al. Human granulocytic Anaplasmosis: a case report in Mexico. J Pediatr Neonatal Care. 2019;9(1):32-34. DOI: 10.15406/jpnc.2019.09.00371

Download PDF

Abstract

Case presentation: We report a case of a 33 month old male patient that presented with a history of rash, diarrhea, fever and lymphadenopathies, admitted to the pediatric unit for a suspected rickettsial infection. The patient was put under empirical antibiotic therapy and underwent analysis, including bonemarrow biopsy, to determine the diagnosis.

Diagnosis: human granulocytic anaplasmosis

Conclusion: Tick borne diseases should be a differential diagnosis in patients presenting with rash and febrile illness with rapid clinical deterioration, especially by clinicians in the north west of Mexico and Mexico-United States border towns.

Keywords: anaplasmosis, zoonoses, tick-borne diseases

Introduction

Human Granulocytic Anaplasmosis (HGA) (previously known as Human Granulocytic Ehrlichiosis, or HGE) is an infectious disease caused by Anaplasma phagocytophilum (previously Rickettsia phagocytophilum in the 1950s, then Ehrlichia phagocytophilum until 2001), a gram-negative obligate intracellular bacteria that is typically transmitted to humans by at least three kinds of ticks, including Ixodes scapularis, Ixodes pacificus, and Dermacentor variabilis, which also transmit Lyme Disease.1 Cases reported to the Centers for Disease Control and Prevention (CDC) have increased steadily since it became a notifiable disease in 2000. The disease is curable if treatment is administered timely, and doxycycline is the number one choice of treatment even in pediatric patients.2

Case description

A 33 month old Mexican male presented to the Hospital de Gineco-Pediatria y Medicina Familiar No. 31, of the Mexican Institute of Social Security (IMSS) in Mexicali, Baja California, México with a week history of fever ranging from 38.5 to 39°C and a non-pruritic macular rash which affected palms and soles, non-bloody diarrhea, and poor appetite. The rash appeared five days after having traveled to a rural area. In the patient’s medical history, it was noted that had an upper respiratory infection treated a week prior, which was treated with ampicillin and acetaminophen, as well as amoebiasis when he was 6 months old. Birth history was unremarkable and he was up-to-date on immunizations. Family history was non-contributory and he had no known sick contacts. The patient lived at home with his parents and three older siblings in an urban neighborhood a block away from a junkyard and auto body shop. The family had one dog as a pet that who had recently had a litter of pups that all died within two weeks of being born. During physical examination, he had a distended and tympanic abdomen. He had a single umbilicated lesion on the ventral aspect of his right forearm. In the emergency department, he was found to have proteinuria of 100mg/dL and leukocytosis to 11.0 K/uL. The remainder laboratory studies were normal. He was diagnosed with gastroenteritis and an unspecific exanthema and treated with intravenous fluids, non-steroidal anti-inflammatory, hydrocortisone, and diphenhydramine.

Clinical progression

He was admitted in the pediatric unit for further evaluation and treatment, and started empirically on intravenous cefotaxime under the suspicion of a bacterial infection. During this period, his white blood cell count increased to 14.8K/uL, yet he was discharged from the hospital five days later due to clinical improvement and without a specific diagnosis. He was re-admitted four days later due to a worsening general condition. His symptoms now included three emetic episodes, headaches, generalized malaise, myalgias, arthralgias, and oral intake intolerance. Physical examination noted that the child was in moderate to severe distress, an axillary temperature of 39°C, dry oral mucosa, cervical, axillary and inguinal lymphadenopathies, hepatosplenomegaly, and a persistent generalized macular rash (Figures 1A–1C). Laboratories revealed lymphocytosis (24.46K/uL), mild elevation of AST (65U/L) and an elevated LDH (413U/L). The rest of the laboratory work-up was unremarkable. At this point, the patient was suffering from systemic inflammatory response syndrome. In order to rule-out specific infectious etiologies, blood, urine, cerebrospinal fluid, pharyngeal, stool, and bronchial cultures were obtained, which turned out negative. Serologies were negative for CMV, EBV, HIV, and HSV.

Twelve days later, rickettsial polymerase chain reaction (PCR) came back negative. Two weeks later, the patient underwent a lymph node biopsy which was consistent with reactive follicular hyperplasia; a second opinion by another pathologist reported reactive lymphoid hyperplasia. A week later, a thoracoabdominal CT scan revealed multiple lymph nodes, all less than an inch in diameter, perihilar and bibasilar alveolar infiltrates with consolidation zones. In the abdomen, the liver appeared homogenous but enlarged without focal or diffuse lesions. Scattered lymph nodes were seen in the mesenteric and inframesocolic chain.

The patient underwent bone marrow aspiration given the leukocytosis and lymphadenopathies, which revealed a reactive bone marrow with predominance of neutrophils and immature forms. In addition, intracytoplasmic inclusions in granulocytes were found (Figure 2). Based on this pathology report, six days later, infectious disease specialists obtained PCR samples, which were sent out to the local school of veterinary medicine´s laboratory, in search for Ehrlichia spp. and Anaplasma spp. Results were positive for Anaplasma spp. and negative for Ehrlichia spp. An additional PCR for Anaplasma phagocytophylum was obtained, which was also positive. (Figure 3) The patient was finally diagnosed with Human Granulocytic Anaplasmosis and treated with oral doxycycline 2.2mg/kg every 12 hours for 14 days according to CDC guidelines and made a full recovery.

Figure 1A Face and chest showing macular rash, 1B Left arm with rash affecting the elbow crease, 1C Palm of the right hand showing rash involvement.
Figure 2 Bone marrow aspirate smear showed presence of intracytoplasmic granulocytic inclusions.
Figure 3 Positive non-nested PCR for Anaplasma phagocytophylum (1,435 base pairs). Numbers 1 to 4 show: marker, patient´s DNA, positive control and negative control.

Discussion

Ehrlichiosis is a general term utilized for zoonotic infections caused by intracellular bacteria from the Anaplasmataceae family, including Ehrlichia chaffeensis, Ehrlichia swingier, and Anaplasma phagocytophylum, which target leukocytes. The type of affected leukocyte depends on the species. E. chaffeensis infects monocytes and is therefore named monocytic ehrlichiosis. Anaplasma phagocytophylum infects granulocytes and is therefore named granulocytic anaplasmosis or granulocytic ehrlichiosis. Both are transmitted by ticks, including Ixodes scapularis, Ixodes pacificus, and Dermacentor variabilis, which also transmit Lyme disease.3 Rickettsiosis encompasses a cluster of different diseases transmitted by vectors that can cause typhoid fever or different kinds of spotted fever (i.e. Rocky Mountain spotted fever, [RMSF]). Some characteristic symptoms or history elements are high-risk behavior, fever, headache, myalgias, arthralgias, rash, multiorgan involvement in late phases of diseases, usually after the second week.4

In this patient, we asked for rickettsia PCR that was collected 48 hours after initiating antibiotic treatment with cefotaxime, a third generation cephalosporin with documented activity against Rickettsia and an accepted second line medication for RMSF. IgG and IgM serology for Rickettsia rickets was not obtained. Historically, anaplasmosis has not been related with dermatological manifestations, usually if they are dermatological symptoms involved, it means there is a coexisting condition with RMSF. It should be noted that, during the time this case developed, there was a unique outbreak of RMSF in Mexicali.5 The progression of disease, 22 days in total, included persistent fever, worsening of general condition, respiratory distress, increasing hepatosplenomegaly and lymphadenopathies, and worsening of laboratory values. This caused the frustration to determine etiology to rise, especially due to the recent local outbreak of RMSF at the time. The differential diagnosis for Rickettsiosis is broad based on the unspecific signs and symptoms. For example, infection with S. aureus can lead to toxic shock syndrome, which is manifested as fever, hypotension, renal insufficiency, and multi organ failure. It is often accompanied by aqueous diarrhea and generalized rash. Similarly, Kawasaki disease, a systemic vasculitis that mainly affects medium-sized arteries, can also lead to multi organ complications. Criteria for diagnosis includes fever >5 days without evident cause, polymorphous rash, cervical lymphadenopathy, conjunctivitis without discharge, edema and erythematic of extremities, and ultimately, periungual desquamation. Oropharyngeal manifestations include swollen lips, pharyngeal hyperemia, and strawberry tongue. Laboratory studies in Kawasaki Disease often reveal elevated WBC with increased immature forms, increased erythrocyte sedimentation rate and protein C, normal platelets in the first week and thrombocytosis as the disease progresses, as well as elevation of LDH. Infectious mononucleosis, which results from infection with cytomegalovirus, Epstein-Barr virus, and others, is characterized by fever, pharyngitis, multiple lymph nodes, splenomegaly, rash, leukocytosis with increased monocytes and atypical lymphocytes.6 The treatment for both Ehrlichiosis and Rickettsiosis is doxycycline, tetracycline, or rifampin (for patients with contraindication to doxycycline or tetracycline like allergies or pregnancy).7 It consists of a 5 to 14 day course of doxycycline 100mg IV or PO every 12hours for adults and 2.2mg/kg PO every 12 hours in the pediatric population, tetracycline 500mg PO every 6hours for adults and 25-50mg/kg/day PO divided into 4 doses in the pediatric population for 5-14days, and rifampicin 300mg PO every 12 hours in adults and 10mg/kg PO every 12 hours for 7-10days in the pediatric population.3 An answer that the emergency department in this hospital implemented for this type of cases (high clinical suspicion, but negative serology or other diagnostic studies) was to introduce an algorithm for the timely diagnosis of rickettsia infections based on a high clinical suspicion since the disease is now endemic to the area.

Conclusion

Tick borne diseases have not traditionally been suspected in the Southwestern United States, and have only recently been made a differential diagnosis that has to be considered by clinicians in the north west of Mexico. Because of the unique border dynamics that occur in this region, increased awareness of the disease by health care providers on either side of the international border is needed in order to identify those symptomatic patients, as well as those at risk of developing the disease.

Acknowledgements

None.

Conflicts of interest

We have no conflicts of interest to disclose.

References

Creative Commons Attribution License

©2019 Soria-Rodríguez, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.